Evelo Biosciences to Present at Upcoming Investor Conferences in June
May 26 2021 - 7:00AM
Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology
company developing a new modality of orally delivered medicines,
today announced that management will present at three upcoming
virtual investor conferences in June:
Jefferies Virtual Healthcare Conference.
Management will host a presentation at 1:30 p.m. ET on Wednesday,
June 2, 2021.
JMP Securities Life Sciences Conference.
Management will host a fireside chat at 1:00 p.m. ET on Wednesday,
June 16, 2021.
Raymond James Human Health Innovation
Conference. Management will host a presentation at 9:20
a.m. ET on Tuesday, June 22, 2021.
Live audio webcasts of the presentations will be available on
the Investors section of the Evelo website at
http://ir.evelobio.com/news-events. A replay of these webcasts will
be available for approximately 30 days following each
presentation.
About Evelo BiosciencesEvelo
Biosciences is a clinical stage biotechnology company developing
orally delivered medicines that act on SINTAX™, the small
intestinal axis, to have systemic therapeutic effects. SINTAX plays
a central role in governing the immune, metabolic, and neurological
systems.
Evelo currently has four product candidates in
development: EDP1815, EDP1867, and EDP2939 for the treatment of
inflammatory diseases and EDP1908 for the treatment of cancer.
Evelo is advancing additional product candidates in other disease
areas.
For more information, please visit
www.evelobio.com and engage with Evelo on LinkedIn.
ContactJessica Cotrone,
978-760-5622jcotrone@evelobio.com
Evelo Biosciences (NASDAQ:EVLO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Evelo Biosciences (NASDAQ:EVLO)
Historical Stock Chart
From Apr 2023 to Apr 2024